AMN Healthcare Services Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AMN Healthcare Services, Inc. on July 15, 2009. The filing reports a significant change in executive management, specifically the appointment of a new Chief Financial Officer.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation and appointment details.
Material Changes
The primary material change is the appointment of Bary Bailey as Chief Financial Officer (CFO). Mr. Bailey began a transitionary role on July 20, 2009, and assumed full CFO responsibilities on August 10, 2009. Mr. David Dreyer served as CFO until August 9, 2009, and transitioned to an advisory capacity through September 30, 2009.
Management Commentary and Compensation
Mr. Bailey brings nearly 30 years of experience in finance and operations within healthcare, insurance, and pharmaceuticals. His compensation package includes:
- Base Salary: $360,000 annually.
- Sign-on Bonus: $100,000 payable on September 1, 2009 (subject to repayment if he leaves within 12 months).
- Annual Bonus: Target of 60% of base salary, with a maximum of 120%, based on the AMN Senior Management Incentive Bonus Plan for the second half of fiscal 2009.
- Equity Grant: 47,929 restricted stock units (three-year cliff vesting) and 219,834 stock appreciation rights (three-year graded vesting), valued at fair market value as of July 20, 2009.
- Benefits: Eligibility for 401(k), Executive Nonqualified Excess Plan, and standard employee benefits.
Investor Verification Checklist
- Verify the exact start date for Mr. Bailey's full CFO responsibilities (August 10, 2009).
- Confirm the repayment terms for the $100,000 sign-on bonus should Mr. Bailey depart within 12 months.
- Review the specific financial performance thresholds required to trigger the target and maximum bonus payouts under the Senior Management Incentive Bonus Plan.
- Check the vesting acceleration conditions tied to the Company's targeted financial performance for the restricted stock units.